Physician profile
Simona Alb
NPI 1578641874
$2,297.99
in general payments reported to CMS, 2019-2025
37 companies · $357 in 2025
The $357 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $78.31 · 2022: $395 · 2023: $235 · 2024: $1,004 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,595.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $295.62 | 2022-2025 | Ubrelvy |
| Abbott Laboratories | $207.26 | 2022-2025 | Aveir, Jot Dx, Gallant |
| Bayer Healthcare Pharmaceuticals INC. | $202.95 | 2024 | |
| Novo Nordisk INC | $199.53 | 2019-2024 | Wegovy |
| Glaxosmithkline, LLC. | $189.49 | 2020-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Astellas Pharma US INC | $148.07 | 2019-2025 | Veozah |
| Radius Health, INC. | $140.94 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $98.89 | 2019-2022 | |
| Phadia US INC. | $65.95 | 2024 | Immunocap |
| Merck Sharp & Dohme LLC | $62.61 | 2019-2020 | |
| Hologic Sales and Service, LLC | $53.10 | 2024-2025 | Aptima |
| Exact Sciences Corporation | $51.63 | 2024 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $47.82 | 2024-2025 | Rexulti |
| Amgen INC. | $44.86 | 2024 | Repatha, Otezla |
| Lilly USA, LLC | $41.54 | 2023-2024 | Zepbound, Mounjaro, Jardiance |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simona Alb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.